Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

930.65

-16.45 (-1.74%)

< Home < Back

Cadila Healthcare informs about Press Release

Date: 01-07-2015

Cadila Healthcare has informed about a Press Release dated July 01, 2015 titled ‘Zydus receives market authorisation for Morphine Sulfate ER Tablets’.

The above information is a part of company’s filings submitted to BSE.